Literature DB >> 17896903

Interaction between warfarin and nafcillin: case report and review of the literature.

Karissa Y Kim1, R J Frey, Kelly Epplen, Farzin Foruhari.   

Abstract

A 39-year-old man with a history of deep vein thrombosis and septic arthritis of the left knee was treated with warfarin and cefazolin. Therapeutic prothrombin times and international normalized ratios (INRs) were maintained with warfarin 32 mg/week for approximately 1 month. When the patient's antibiotic regimen was changed from cefazolin to nafcillin 2 g every 4 hours, his INR declined significantly. His warfarin dosage had to be increased to a maximum of 88 mg/week to achieve a therapeutic INR. After completion of antibiotic therapy with nafcillin, the patient's warfarin requirements slowly declined over several weeks. A maintenance dosage of warfarin 42-48 mg/week was necessary after nafcillin discontinuation. Hepatic cytochrome P450 isoenzyme induction by nafcillin is likely the mechanism of a warfarin-nafcillin interaction. The usual onset of effect is within 1 week after starting nafcillin, and the offset of the effect is usually evident within 4 weeks after nafcillin discontinuation. In patients taking warfarin who are prescribed nafcillin, a 2-4-fold increase in the warfarin dose may be necessary, and clinicians should closely monitor INRs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17896903     DOI: 10.1592/phco.27.10.1467

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

1.  Warfarin-flucloxacillin interaction presenting as cardioembolic ischemic stroke.

Authors:  Aine Merwick; Niamh Hannon; Peter J Kelly; Killian O'Rourke
Journal:  Eur J Clin Pharmacol       Date:  2010-03-05       Impact factor: 2.953

2.  A probable clinically significant interaction between warfarin and cloxacillin: three case reports.

Authors:  Hossein Khalili; Naemeh Nikvarz; Farhad Najmeddin; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2012-09-04       Impact factor: 2.953

Review 3.  Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.

Authors:  Leigh Anne Hylton Gravatt; Rachel W Flurie; Estela Lajthia; Dave L Dixon
Journal:  Curr Atheroscler Rep       Date:  2017-10-09       Impact factor: 5.113

4.  Significant drug-drug interaction between warfarin and nafcillin.

Authors:  Cynthia A King; Kathleen M Babcock; Rhianna J Godios; Benjamin S King
Journal:  Ther Adv Drug Saf       Date:  2018-08-31

Review 5.  Drug Interactions Affecting Oral Anticoagulant Use.

Authors:  Philip L Mar; Rakesh Gopinathannair; Brooke E Gengler; Mina K Chung; Arturo Perez; Jonathan Dukes; Michael D Ezekowitz; Dhanunjaya Lakkireddy; Gregory Y H Lip; Mike Miletello; Peter A Noseworthy; James Reiffel; James E Tisdale; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.